Orthofix Medical (OFIX) vs OraSure Technologies (OSUR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
OraSure Technologies (OSUR) has outperformed Orthofix Medical (OFIX) over the past year, gaining 52.4% versus a loss of 60.2%. Over five years, OSUR leads with a -63.7% price change compared with -80.6% for OFIX. Orthofix Medical is the larger company by market cap ($247.4 million vs $238.9 million), about 1.0 times the size.
Orthofix Medical converts more of its revenue into profit, with a net margin of -11.2% versus -59.8%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | OFIX | OSUR |
|---|---|---|
| Share price | $6.07 | $3.46 |
| Market cap | $247.41M | $238.90M |
| 1-day change | -4.26% | -4.16% |
| YTD return | -59.96% | +42.98% |
| 1-year return | -60.22% | +52.42% |
| 5-year return | -80.64% | -63.69% |
| Forward P/E | 33.72 | — |
| EPS (TTM) | $-1.10 | $-0.69 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $822.31M | $115.02M |
| Revenue growth (YoY) | +2.85% | -38.10% |
| Net income (latest FY) | $-92.19M | $-68.73M |
| Gross margin | 68.83% | 41.90% |
| Operating margin | -9.90% | -62.57% |
| Net margin | -11.21% | -59.76% |
| 52-week high | $16.42 | $4.58 |
| 52-week low | $6.04 | $2.28 |
| Distance from 52-week high | -63.03% | -24.45% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +64.74% | +58.96% |
| Average volume | 481.16K | 571.50K |
| Shares outstanding | 40.76M | 69.05M |
| Employees | 1,605 | 500 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- OSUR has outperformed OFIX by 112.6 percentage points over the past year.
- Orthofix Medical is more profitable, keeping -11.2 cents of every revenue dollar as net income versus -59.8 cents for OraSure Technologies.
- Orthofix Medical grew revenue faster in its latest fiscal year (+2.85% vs -38.10%).
About Orthofix Medical
OFIX stock →Orthofix Medical Inc., together with its subsidiaries, operates as a medical technology company in the United States, Italy, the United Kingdom, France, Germany, Brazil, and internationally. It operates through two segments, Global Spine and Global Limb Reconstruction.
Health Care · Medical/Dental Instruments · 1,605 employees
About OraSure Technologies
OSUR stock →OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, sells, and distributes diagnostic products and specimen collection devices in the United States, Europe, Africa, and internationally. It offers OraQuick Rapid HIV test, OraQuick HIV self-test, OraQuick HIV self-test(international), OraQuick HCV rapid antibody test and self-test, Syphilis health check rapid diagnostic test, OraQuick Ebola rapid antigen test, InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, SickleSCAN test, and OraSure oral fluid collection device for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D.
Health Care · Medical/Dental Instruments · 500 employees
OFIX vs OSUR FAQ
Which is bigger, Orthofix Medical or OraSure Technologies?
Orthofix Medical (OFIX) is larger, with a market capitalization of $247.41M compared with $238.90M for OraSure Technologies (OSUR).
Which stock has performed better over the past year, OFIX or OSUR?
OSUR returned +52.42% over the past 12 months, compared with -60.22% for OFIX (price return, excluding dividends). Past performance does not predict future results.
Are Orthofix Medical and OraSure Technologies in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.